VTEval Project - A Prospective Cohort Study to Evaluate Diagnosis, Management and Outcome in Individuals with Venous Thromboembolism (VTE)

• Head of study: Professor Philipp Wild, MD
                       Professor Stavros V. Konstantinides, MD (co-speaker)
• ClinicalTrials.gov - ID-No.:  NCT02156401

Summary

Venous thromboembolism (VTE) with its two clinical manifestations deep vein thrombosis (DVT) and pulmonary embolism (PE) is a life-threating disease that is associated with considerable morbidity and mortality. The incidence of VTE increases with age and it - as the third most common cardiovascular disease after ischemic heart disease and stroke - represents an important public health problem in industrialized countries.

 

VTEval Project is a long-term prospective observational study to evaluate and improve VTE diagnostics and management, treatment and outcome. The aims of the project include a systematic assessment of VTE, i.e. disease status (symptoms, clinical and subclinical aspects) and risk profiles (classic, psychosocial and environmental factors), using a system-oriented approach. VTEval collects three large prospective cohorts of patients with suspected and incident VTE, and its standardized and harmonized data acquisition establishes a sustainable resource for comprehensive research on VTE, providing the basis for both short- and long-term analysis.

Study Design	Prospective cohort study
Official Title	VTEval Project - A Prospective Cohort Study to Evaluate Diagnosis, Management and Outcome in Individuals with Venous Thromboembolism
Study start	April 2013
Enrollment	approx. 2000 individuals
Study Length per Individual	5 years
Follow-up Examination	Medical examination, computer-assisted personal and telephone interviews (CAPI/CATI), information from registry offices
Status	Recruiting
Steering Committee	Philipp Wild, Mainz, Stavros V. Konstantinides, Mainz, Thomas Münzel, Mainz, Karl Lackner, Mainz, Christine Espinola-Klein, Mainz